title: Protective effects of lazaroid U74389G on intestinal graft after heterotopic small bowel transplantation in rats.
abstract: BACKGROUND
  Experimental studies have shown that 21-aminosteroids (21-A) are powerful inhibitors of superoxide-mediated iron-dependent lipid peroxidation. This study was aimed at determining how far the blocking effect of one of these substances (lazaroid U74389G) on lipid peroxidation protects intestinal grafts morphologically and biologically in a heterotopic transplant model (SBT) in rats.
  
  
  METHODS
  Heterotopic LEW were performed using Ringer lactate (4 degrees C) as preservation solution. In Group 1 (n = 7) the donor and recipient animals received 3 and 6 mg/kg of the 21-A U74389G, respectively. Group 2 (n = 7) received the same doses of the vehicle of the drug. Sham group underwent only a laparotomy. Bacterial translocation (BT) was determined in mesenteric lymph nodes (MLN), liver (L), and spleen (S) 60 min after reperfusion. Tissue myeloperoxidase (MPO), malondialdehyde (MDA), and percentage conversion xanthine dehydrogenase/xanthine oxidase (XD/XO) were also determined in the ileal graft. Histological damage was graded according to Park's classification.
  
  
  RESULTS
  Tissue MDA (nmol/mg prot) was significantly lower in Group 1 (0.53 +/- 0.09) than in Group 2 (3.66 +/- 1, P < 0.05) and showed levels similar to those of the sham-operated group (0.40 +/- 0.05). Injury grades were also significantly different in both study groups (Group 1, 0-1; Group 2, 2-3, P < 0.05). BT (log CFU/g tissue) in Group 1 were MLN, 0; L, 0.36; and S, 0. In Group 2, MLN, 1.07; L, 0.81; and S, 1.49 (P < 0.05 in MLN). Increase in MPO activity (U/g prot) in comparison with sham-operated animals was similar in the two study groups (Group 1, 1.49 +/- 0.58; Group 2, 1.22 +/- 0.46; Sham, 0.34 +/- 0.37 (P < 0.05 1,2 vs sham). Conversion of XD to XO was unaffected by the supplementation of the drug.
  
  
  CONCLUSIONS
  21A U74389G inhibits lipid peroxidation, protects intestinal graft, and reduces BT after heterotopic SBT in rats.
authors.affiliation: Department of Surgery, C.S.U.B. Hospital Prínceps d'Espanya, University of Barcelona, Spain. jdeoca@medicina.ub.es
authors.forename: J
authors.initials: J
authors.lastname: de Oca
authors.forename: S
authors.initials: S
authors.lastname: Cuadrado
authors.forename: J
authors.initials: J
authors.lastname: Vallet
authors.forename: C
authors.initials: C
authors.lastname: Benasco
authors.forename: E
authors.initials: E
authors.lastname: Martín
authors.forename: C
authors.initials: C
authors.lastname: Ardanuy
authors.forename: D
authors.initials: D
authors.lastname: Closa
authors.forename: G
authors.initials: G
authors.lastname: Hotter
authors.forename: E
authors.initials: E
authors.lastname: Jaurrieta
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D018988:Bacterial Translocation / Q000187:drug effects; D007421:Intestine, Small / Q000637:transplantation*; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D011281:Pregnatrienes / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D014968:Xanthine Dehydrogenase / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D000975:Antioxidants; D011281:Pregnatrienes; C074965:U 74389F; D008315:Malondialdehyde; D009195:Peroxidase; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase